Brief: Vivos Therapeutics Receives Notice From Nasdaq Regarding Late Filing Of Third Quarter 2022 Quarterly Report On Form 10-Q
28/11/2022 21:49
Nov 28 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ
REGARDING LATE FILING OF THIRD QUARTER 2022 QUARTERLY REPORT ON
FORM 10-Q
Source text for Eikon: ID:nGNX4Sd8pJ
Further company coverage: VVOS.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth